![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 215/22 | |
C07C 305/24 | |||
C07C 233/60 | |||
A61K 31/47 | |||
A61P 35/00 | |||
C07D 215/60 | |||
G01N 33/487 |
(11) | Number of the document | 2970126 |
(13) | Kind of document | T |
(96) | European patent application number | 14721149.4 |
Date of filing the European patent application | 2014-03-17 | |
(97) | Date of publication of the European application | 2016-01-20 |
(45) | Date of publication and mention of the grant of the patent | 2019-03-06 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2014/030524 |
Date | 2014-03-17 |
(87) | Number | WO 2014/145715 |
Date | 2014-09-18 |
(30) | Number | Date | Country code |
201361792413 P | 2013-03-15 | US |
(72) |
AFTAB, Dana, T., US
NAGANATHAN, Sriram, US
XU, Wei, US
LACY, Steven, US
NGUYEN, Linh, US
|
(73) |
Exelixis, Inc.,
1851 Harbor Bay Parkway, Alameda, CA 94502,
US
|
(54) | METABOLITES OF N-(4-{[6,7-BIS(METHYLOXY)QUINOLIN-4-YL]OXY}PHENYL)-N`-(4-FLUOROPHENYL) CYCLOPROPANE-1,1-DICARBOXAMIDE |
METABOLITES OF N-(4-{[6,7-BIS(METHYLOXY)QUINOLIN-4-YL]OXY}PHENYL)-N`-(4-FLUOROPHENYL) CYCLOPROPANE-1,1-DICARBOXAMIDE |